Clinical Characteristics, Risk Factors, and Outcomes of POEMS Syndrome
Neurol 95:e268-e279, Keddie, S.,et al, 2020
Clinicopathologic Features, Pathogenesis, and Treatment of Monoclonal Gammopathy-Associated Myopathies
Neurol 105:213101, Soontrapa,P.,et al, 2025
A Young Woman with Blurred Vision and Distal Paresthesias
JAMA Neurol 72:1519-1523, Kung, N.H.,et al, 2015
A 48-year-old Man with Walking Difficulty
Neurol 85:e165-e169, Kalladka, D.,et al, 2015
Cerebral Infarction in POEMS Syndrome: Incidence, Risk Factors, and Imaging Characteristics
Neurol 73:1308-1312, Dupont,S.A.,et al, 2009
POEMS Syndrome Associated with Ischemic Stroke
Arch Neurol 60:745-749, Kang, K.,et al, 2003
The Neurologic Complications of Scleromyxedema
Medicine 80:313-319, Berger,J.R.,et al, 2001
Prognosis of patients with Primary Systemic Amyloidosis Who Present with Dominant Neuropathy
Am J Med 104:232-237, Rajkumar,S.V.,et al, 1998
POEMS Syndrome:A Study of 25 Cases and a Review of the Literature
Am J Med 97:543-553, Soubrier,M.J.,et al, 1994
Clinicopath Conf
Castleman's Disease, Synd of Polyneuropathy, Organomegally, Endocrinopathy, Monoclonal Gammopathy, &, Skin CPOEM Synd),NEJM 316:606-618,1987., 1987